HUP0800527A2 - Urocortine 3 fragments and analogues, process for their preparation and use for the treatment of depression and anxiety - Google Patents

Urocortine 3 fragments and analogues, process for their preparation and use for the treatment of depression and anxiety

Info

Publication number
HUP0800527A2
HUP0800527A2 HU0800527A HUP0800527A HUP0800527A2 HU P0800527 A2 HUP0800527 A2 HU P0800527A2 HU 0800527 A HU0800527 A HU 0800527A HU P0800527 A HUP0800527 A HU P0800527A HU P0800527 A2 HUP0800527 A2 HU P0800527A2
Authority
HU
Hungary
Prior art keywords
urocortine
anxiety
analogues
fragments
depression
Prior art date
Application number
HU0800527A
Other languages
Hungarian (hu)
Inventor
Gyula Dr Telegdy
Gabor Dr Toth
Kinga Kadar
Masaru Tanaka
Original Assignee
Univ Szegedi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Szegedi filed Critical Univ Szegedi
Priority to HU0800527A priority Critical patent/HUP0800527A2/en
Publication of HU0800527D0 publication Critical patent/HU0800527D0/en
Priority to PCT/HU2009/000079 priority patent/WO2010020825A2/en
Publication of HUP0800527A2 publication Critical patent/HUP0800527A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
HU0800527A 2008-08-22 2008-08-22 Urocortine 3 fragments and analogues, process for their preparation and use for the treatment of depression and anxiety HUP0800527A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU0800527A HUP0800527A2 (en) 2008-08-22 2008-08-22 Urocortine 3 fragments and analogues, process for their preparation and use for the treatment of depression and anxiety
PCT/HU2009/000079 WO2010020825A2 (en) 2008-08-22 2009-08-19 Urocortin 3 fragments and analogs, their preparation and use as antidepressive and anxiolytic agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0800527A HUP0800527A2 (en) 2008-08-22 2008-08-22 Urocortine 3 fragments and analogues, process for their preparation and use for the treatment of depression and anxiety

Publications (2)

Publication Number Publication Date
HU0800527D0 HU0800527D0 (en) 2008-10-28
HUP0800527A2 true HUP0800527A2 (en) 2011-03-28

Family

ID=89988472

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0800527A HUP0800527A2 (en) 2008-08-22 2008-08-22 Urocortine 3 fragments and analogues, process for their preparation and use for the treatment of depression and anxiety

Country Status (2)

Country Link
HU (1) HUP0800527A2 (en)
WO (1) WO2010020825A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1247012A1 (en) * 1983-07-13 1986-07-30 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср Substituted 3-hydrazine-propionate or their pharmaceutically suitable salts possessing arrhythmic activity
CA2425902C (en) * 2001-03-15 2017-01-03 Research Development Foundation Urocortin-iii and uses thereof

Also Published As

Publication number Publication date
WO2010020825A2 (en) 2010-02-25
HU0800527D0 (en) 2008-10-28
WO2010020825A3 (en) 2010-04-15

Similar Documents

Publication Publication Date Title
EP2078051A4 (en) Process for producing polysiloxanes and use of the same
EP2212440A4 (en) Methods and compositions for the diagnosis and treatment of esphageal adenocarcinomas
IL216967B (en) 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives and use thereof for the treatment of diseases
EP2260109A4 (en) Microrna-based methods and compositions for the diagnosis, pronosis and treatment of prostate related disorders
SG10201408158SA (en) Composition and methods used during anti-hiv treatment
HK1146894A1 (en) Compositions and methods for treating diseases of the nail
IL214396A (en) Carba-nucleosides for antiviral treatment, pharmaceutical compositions comprising the same and methods of making carba-nucleosides and intermediates of carba-nucleosides for antiviral treatment
EP2297341A4 (en) Methods and compositions for the treatment of huntington's disease
HUE043807T2 (en) Glyx for use in the treatment of alzheimer's disease, parkinson's disease or huntington's disease
EP2189486A4 (en) Low-melt-viscosity polyglycolic acid, process for producing the same, and use of the low-melt-viscosity polyglycolic acid
IL220682A0 (en) 1h-quinazoline-2,4-diones, processes for their manufacture, and use thereof in the preparation of medicaments for treating conditions mediated by the ampa-receptor
IL211313A0 (en) Compounds, compositions and methods for the treatment of ??-amyloid diseases and synucleinopathies
EP2217238A4 (en) Methods and compositions for the treatment of proteinuric diseases
ZA201101517B (en) Compositions for the prophylaxis and treatment of dermatological/mucosal diseases,and uses thereof
GB0909297D0 (en) Composition for the treatment of skin conditions
EP2255835A4 (en) Medical instrument, medical material, and method for production of the medical instrument and medical material
EP2502989A4 (en) Implant composition for the regeneration of neural tissue, process of preparation and uses thereof
WO2010085799A9 (en) Compositions and method for the treatment of parkinson's disease
PL2044099T3 (en) Process for the preparation of s-fluoromethyl-6 ,9 -difluoro-11 -hydroxy-16 -methyl-17 -propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates
EP2459194A4 (en) Compositions and methods for treating parkinson's disease
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
IL207668A0 (en) Beloxepin, its enantiomers, and analogs thereof for the treatment of pain
PL2307380T3 (en) N'-nitroxyalkylnicotinamides for the treatment of cardiovascular diseases
HU0800527D0 (en) Urocortine 3 fragments and analogues, process for their preparation and use for the treatment of depression and anxiety
PT2190913E (en) Method for the production of aqueous formulations, aqueous formulations, and the use thereof

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees